Хирургические методы коррекции свищей при раке шейки матки после проведения лучевой терапии

Целью работы являлся анализ имеющейся информации о рисках формирования свищей у больных раком шейки матки после лучевой терапии, а также о возможных методах лечения.
В обзор литературы включены работы англоязычных и отечественных авторов, посвященные этой теме. Рассмотрена актуальность проблемы формирования свищей после проведения лучевой терапии при раке шейки матки, освещены некоторые подходы к терапии данной патологии.
Попытки изменить подходы к лучевой терапии при распространенных стадиях рака шейки матки оказались неудачными, в связи с чем риск формирования свищей у пациенток с РШМ будет высоким и в последующие годы. Применение различных методов в лечении свищей также показывает противоречивые результаты и диктует необходимость действовать индивидуально в каждой конкретной ситуации. И по-прежнему актуальна разработка новых хирургических методов коррекции везиковагинальных и ректовагинальных свищей.

1. Злокачественные новообразования в России в 2019 г. (заболеваемость и смертность). Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. 252 с. [Malignant tumors in Russia in 2019 (incidence and mortality). Ed. by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzodova. Moscow: P.A. Herzen Moscow Oncology Research Institute - a branch of the National Medical Research Center of Radiology, Ministry of Health of Russia, 2020. 252 p. (In Russ.)].

2. Состояние онкологической помощи населению России в 2019 г. Под ред. А.Д. Каприна, В.В. Старинского, А.О. Шахзадовой. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2020. 239 с. [Situation with cancer care in Russia in 2019. Ed. by A.D. Kaprin, V.V. Starinskiy, A.O. Shakhzadova. Moscow: P.A. Herzen Moscow Oncology Research Institute - a branch of the National Medical Research Center of Radiology, Ministry of Health of Russia, 2020. 239 p. (In Russ.)].

3. Mosalaei A., Mohammadianpanah M., Omidvari S. et al. High-dose rate brachytherapy in the treatment of carcinoma of uterine cervix: twenty-year experience with cobalt after-loading system. Int J Gynecol Cancer 2006;16:1101-5.

4. Chaney A.W., Eifel P.J., Logsdon M.D. et al. Mature results of a pilot study of pelvic radiotherapy with concurrent continuous infusion intra-arterial 5-FU for stage IIIBYIVA squamous cell carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1999;45:113-8.

5. Angioli R., Penalver M., Muzii L. et al. Guidelines of how to manage vesicovaginal fistula. Crit Rev Oncol Hematol 2003;48(3):295-304.

6. Moore K.N., Gold M.A., McMeekin D.S., Zorn K.K. Vesicovaginal fistula formation in patients with Stage IVA cervical carcinoma. Gynecol Oncol 2007;106(3):498-501.

7. Biewenga P., Mutsaerts M.A., Stalpers L.J. et al. Can we predict vesicovaginal or rectovaginal fistula formation in patients with stage IVA cervical cancer? Int J Gynecol Cancer 2010;20(3):471-5.

8. Syed A.M., Puthawala A.A., Abdelaziz N.N. et al. Longterm results of low-dose-rate interstitial-intracavitary brachytherapy in the treatment of carcinoma of the cervix. Int J Radiat Oncol Biol Phys 2002;54(1):67-78.

9. Wang J., Boerma M., Fu Q., HauerJenson M. Radiation responses in skin and connective tissues. Hernia 2006;10(6):502-6

10. Tokarek R., Bernstein E.F., Sullivan F. et al. Effect of therapeutic radiation on wound healing. Clin Dermatol 1994;12(1):57-70.

11. Stewart A., Bentzen S. Radiobiological aspects of brachytherapy in the era of 3-dimensional imaging. In: Gynecologic radiation therapy: novel approaches to image-guidance and management. Berlin: Springer, 2011. Pp. 131-142.

12. Feddock J,, Randall M,, Kudrimoti M. et al. Impact of post-radiation biopsies on development of fistulae in patients with cervical cancer. Gynecol Oncol 2014;133(2):263-7.

13. Marnitz S., Kohler C., Muller M. et al. Indications for primary and secondary exenterations in patients with cervical cancer. Gynecol Oncol 2006;103:1023-30.

14. De Wilt J.H., van Leeuwen D.H., Logmans A. et al. Pelvic exenteration for primary and recurrent gynaecological malignancies. Eur J Obstet Gynecol Reprod Biol 2007;134:243-8.

15. Rodriguez-Bigas M.A., Petrelli N.J. Pelvic exenteration and its modifications. Am J Surg 1996;171:293-8.

16. Barraclough L.H., Swindell R., Livsey J.E. et al. External beam boost for cancer of the cervix uteri when intracavitary therapy cannot be performed. Int J Radiat Oncol Biol Phys 2008;71(3):772-8.

17. Haas J.A., Witten M.R., Clancey O. et al. CyberKnife boost for patients with cervical cancer unable to undergo brachytherapy. Front Oncol 2012;2:25.

18. Kubicek G.J., Xue J., Xu Q. et al. Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer. Biomed Res Int 2013;2013:898953.

19. Hsieh C.H., Tien H.J., Hsiao S.M. et al. Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients - a preliminary result. OncoTargets Ther 2013;6:59-66.

20. Marnitz S., Köhler C., Budach V. et al. Brachytherapy-emulating robotic radiosurgery in patients with cervical carcinoma. Rad Oncol 2013;8(1):109.

21. Albuquerque K., Tumati V., Lea J. et al. A phase II trial of stereotactic ablative radiation therapy as a boost for locally advanced cervical cancer. Int J Radiat Oncol Biol Phys 2020;106(3):464-71.

22. Eifel P.J., Winter K., Morris M. et al. Pelvic irradiation with concurrent chemotherapy versus pelvic and paraaortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. J Clin Oncol 2004;22(5):872-80.

23. Rose P.G., Bundy B.N., Watkins E.B. et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 1999;340(15):1144-53.

24. Charra-Brunaud C., Harter V., Delannes M. et al. Impact of 3D imagebased PDR brachytherapy on outcome of patients treated for cervix carcinoma in France: results of the French STIC prospective study. Radiother Oncol 2012;103(3):305-13.

25. Sturdza A., Potter R., Fokdal L.U. et al. Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study. Radiother Oncol 2016;120(3):428-33.

26. Koumantakis E., Haralambakis Z., Koukourakis M. et al. A pilot study on concurrent platinum chemotherapy and intracavitary brachytherapy for locally advanced cancer of the uterine cervix. Br J Radiol 1998;71(845):552-7.

27. Kim Y.J., Kang H.-C., Kim Y.S. Impact of intracavitary brachytherapy technique (2D versus 3D) on outcomes of cervical cancer: a systematic review and metaanalysis. Strahlenther Onkol 2020;196:973-82.

28. Pötter R. Knocke T., Fellner C. et al. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations. Cancer Radiother 2000;4(2):159-72.

29. Kirchheiner K., Nout R.A., Tanderup K. et al. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study. Int J Radiat Oncol Biol Phys 2014;89(1):88-95.

30. Mazeron R., Fokdal L.U., Kirchheiner K. et al. Dose-volume effect relationships for late rectal morbidity in patients treated with chemoradiation and MRI-guided adaptive brachytherapy for locally advanced cervical cancer: Results from the prospective multicenter EMBRACE study. Radiother Oncol 2016;120(3):412-9.

31. Wit E.M.K., Horenblas S. Urological complications after treatment of cervical cancer. Nat Rev Urol 2014;11(2):110-7.

32. Virdee N.K., Ringdal E.K., Thornhill H. et al. Gynaecological fistulae after surgery or radiotherapy. Tidsskr Nor Laegeforen 2020;140(12).

33. Margolin D.J., Gonzalez R.P. Retrospective analysis of traumatic bladder injury: does suprapubic catheterization alter outcome of healing? Am Surg 2004;70:1057-60.

34. Segreti E.M., Levenback C., Morris M. et al. A comparison of end and loop colostomy for fecal diversion in gynecologic patients with colonic fistulas. Gynecol Oncol 1996;60:49-53.

35. Jereczek-Fossa B., Jassem J., Nowak R., Badzio A. Late complications after postoperative radiotherapy in endometrial cancer: analysis of 317 consecutive cases with application of linear-quadratic model. Int J Radiat Oncol Biol Phys 1998;41:329-38.

36. Pedersen D., Bentzen S.M., Overgaard J. Reporting radiotherapeutic complications in patients with uterine cervical cancer. The importance of latency and classification system. Radiother Oncol 1993;28:134-41.

37. Piekaeki J.H., Jereczek-Fossa B.A., Nejc D. et al. Does fecal diversion offer any chance for spontaneous closure of the radiationinduced rectovaginal fistula? Int J Gynecol Cancer 2008;18:66-70.

38. Greven K.M., Corn B.W. Endometrial cancer. Curr Probl Cancer 1997;21:65-127.

39. Lanciano R.M., Martz K., Montana G.S., Hanks G.E. Influence of age, prior abdominal surgery, fraction size, and dose on complication after radiation therapy for squamous cell cancer of the uterine cervix: a pattern of care study. Cancer 1992;69:2124-30.

40. Nowacki M.P. Ten years of experience with Park’s coloanal sleeve anastomosis for the treatment of post-irradiation rectovaginal fistula. Eur J Surg Oncol 1991;17:563-6.

41. Fontes B., Fontes W., Utiyama E.M., Birolini D. The efficacy f loop colostomy for complete fecal diversion. Dis Colon Rectum 1988;31:298-302.

42. Hallfeldt K., Schmidbauer S., Trupka A. Laparoscopic loop colostomy and advanced ovarian cancer, rectal cancer and rectovaginal fistulas. Gynecol Oncol 2000;76:380-2.

43. Hanks G.E., Herring D.F., Kramer S. Patterns of care outcome studies. Results of the national practice in cancer of the cervix. Cancer 1983;51:959-67.

44. Palmer J.A., Bush R.S. Radiation injuries to the bowel associated with the treatment of carcinoma of the cervix. Surgery 1976;80:458-64.

45. Schmidt J.D., Buchsbaum H.J. Transverse colon conduit diversion. Urol Clin North Am 1986;13:233-9.

46. White A.J., Buchsbaum H.J., Blythe J.G., Lifshitz S. Use of bulbocavernosus muscle (Martius procedure) for repair of radiationinduced rectovaginal fistulas. Obstet Gynecol 1982;60:114-8.

47. Tei T.M., Stolzenburg T., Buntzen S. et al. Use of transpelvic rectus abdominis musculocutaneous flap for anal cancer salvage surgery. Br J Surg 2003;90:575-80.

48. Viennas L.K., Alonso A.M., Salama V. Repair of radiation-induced vesicovaginal fistula with a rectus abdominis myocutaneous flap. Plast Reconstr Surg 1995;96:1435-7.

49. Bricker E.M., Johnston W.D., Kraybill W.G., Lopez M.J. Reconstructive surgery for the complications of pelvic irradiation. Am J Clin Oncol 1984;7:81-9.

50. Sværdborg M., Birke-Sørensen H., Bek K.M., Nielsen J.B. A modified surgical technique for treatment of radiation-induced vesicovaginal fistulas. Urology 2012;79(4):950-3.

51. Burger R.A., Riedmiller H., Knapstein P.G. et al. Ileocecal vaginal reconstruction. Am J Obstet Gynecol 1989;161:162-7.

52. Hensle T.W., Reiley E.A. Vaginal replacement in children and young adults. J Urol 1998;159:1035-8.

53. Lacey C.G., Stern J.L., Feigenbaum S. et al. Vaginal reconstruction after exenteration with use of gracilis myocutaneous flaps: the University of California, San Francisco experience. Am J Obstet Gynecol 1988;158:1278-84.

54. Palmer J.A., Vernon C.P., Cummings B.J., Moffat F.L. Gracilis myocutaneous flap for reconstructing perineal defects resulting from radiation and radical therapy. Can J Surg 1983;26:510-12.

55. Hockel M. The transversus and rectus abdominis musculoperitoneal (TRAMP) composite flap for vulvovaginal reconstruction. Plast Reconstr Surg 1996;97:455-9.

56. Gleeson N.C., Baile W., Roberts W.S. et al. Pudendal thigh fasiocutaneous flaps for vaginal reconstruction in gynecologic oncology. Gynecol Oncol 1994;54:269-74.

57. Ratliff C.R., Gershenson D.M., Morris M. et al. Sexual adjustment of patients undergoing gracilis myocutaneous flap vaginal reconstruction in conjunction with pelvic exenteration. Cancer 1996;78:2229-35.

58. Ивашков В.Ю., Сопромадзе С.В., Доколин Р.М. и др. Применение метода гипербарической оксигенации для лечения осложнений после реконструктивных операций в онкологии. Саркомы костей, мягких тканей и опухоли кожи 2017;(1):46-51. [Ivashkov V.Yu., Sopromadze S.V., Dokolin R.M. et al. Hyperbaric oxygenation for the treatment of complications after reconstructive cancer surgeries. Sarkomy kostey, myagkikh tkaney i opukholi kozhi = Sarcomas of Bones, Soft Tissues, and Skin Tumors 2017;(1):46-51. (In Russ.)].